These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33421136)

  • 21. Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours.
    Gerdtsson A; Negaard HFS; Almås B; Bergdahl AG; Cohn-Cedermark G; Glimelius I; Halvorsen D; Haugnes HS; Hedlund A; Hellström M; Holmberg G; Karlsdóttir Á; Kjellman A; Larsen SM; Thor A; Wahlqvist R; Ståhl O; Tandstad T
    BJU Int; 2024 Jun; 133(6):717-724. PubMed ID: 38293778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.
    Funt SA; Patil S; Feldman DR; Motzer RJ; Bajorin DF; Sheinfeld J; Tickoo SK; Reuter VE; Bosl GJ
    J Clin Oncol; 2019 Sep; 37(26):2329-2337. PubMed ID: 31233353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the Testis.
    Nason GJ; Donahoe L; de Perrot M; Aditya I; Jewett MAS; Bedard PL; Hansen AR; Chung P; Warde P; Anson-Cartwright L; Sweet J; O'Malley M; Atenafu EG; Hamilton RJ
    Urology; 2020 Apr; 138():69-76. PubMed ID: 32004556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC; McBride LC
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?
    Beck SD; Foster RS; Bihrle R; Cheng L; Donohue JP
    J Urol; 2005 Oct; 174(4 Pt 1):1287-90; discussion 1290. PubMed ID: 16145394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.
    Calaminus G; Schneider DT; Weissbach L; Schönberger S; Okpanyi V; Leuschner I; Poremba C; Göbel U
    Klin Padiatr; 2009; 221(3):136-40. PubMed ID: 19437360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
    Douglawi A; Calaway A; Tachibana I; Panizzutti Barboza M; Speir R; Masterson T; Adra N; Foster R; Einhorn L; Cary C
    J Urol; 2020 Jul; 204(1):96-103. PubMed ID: 32003612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy.
    Mousa A; Anson-Cartwright L; Atenafu EG; Jewett MAS; Bedard P; Jiang DM; Glicksman R; Chung P; Warde P; O'Malley M; Prendeville S; Hamilton RJ
    BJU Int; 2024 Oct; 134(4):622-629. PubMed ID: 38967557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
    Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
    Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
    Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
    Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.
    Hamilton RJ; Nayan M; Anson-Cartwright L; Atenafu EG; Bedard PL; Hansen A; Chung P; Warde P; Sweet J; O'Malley M; Sturgeon J; Jewett MAS
    J Clin Oncol; 2019 Aug; 37(22):1919-1926. PubMed ID: 30802156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
    Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
    World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
    Carver BS; Cronin AM; Eggener S; Savage CJ; Motzer RJ; Bajorin D; Bosl GJ; Sheinfeld J
    Urology; 2010 Jun; 75(6):1431-5. PubMed ID: 20299079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.